{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:47:20Z","timestamp":1791542840691,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1053\/j.gastro.2021.09.055","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T14:59:45Z","timestamp":1632927585000},"page":"88-108.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-6129","authenticated-orcid":false,"given":"Atsushi","family":"Sakuraba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Micic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2021.09.055_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.09.055_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/annrheumdis-2021-220418","article-title":"Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry","volume":"80","author":"Sparks","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"80","author":"Akiyama","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.055_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/BOR.0000000000000725","article-title":"Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases","volume":"32","author":"Gianfrancesco","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.055_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib7","first-page":"3533","article-title":"Patients with inflammatory bowel disease are not at increased risk of COVID-19: a large multinational cohort study","volume":"9","author":"Allocca","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1053\/j.gastro.2021.09.055_bib8","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.09.055_bib9","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2-preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.09.055_bib10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ecco-jcc\/jjab046","article-title":"SARS-CoV-2 vaccination in IBD: past lessons, current evidence and future challenges","volume":"15","author":"Wellens","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.055_bib11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-T","article-title":"Antigen-specific antibody responses in lupus patients following immunization","volume":"41","author":"Battafarano","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2021.09.055_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","article-title":"The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Elkayam","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/j.gastro.2021.09.055_bib13","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/gutjnl-2021-324789","article-title":"Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.055_bib14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2021.09.055_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/2046-4053-2-111","article-title":"PROSPERO\u2019s progress and activities 2012\/13","volume":"2","author":"Booth","year":"2013","journal-title":"Syst Rev"},{"key":"10.1053\/j.gastro.2021.09.055_bib16","unstructured":"Aromataris E, Munn Z, eds. JBI Manual for Evidence Synthesis. 2020. Available at: https:\/\/synthesismanual.jbi.global. Accessed July 1, 2021."},{"key":"10.1053\/j.gastro.2021.09.055_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2021.09.055_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2021.09.055_bib19","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"10.1053\/j.gastro.2021.09.055_bib20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1053\/j.gastro.2021.09.055_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2021.09.055_bib22","author":"Clyne"},{"key":"10.1053\/j.gastro.2021.09.055_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1053\/j.gastro.2021.09.055_bib24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/annrheumdis-2021-220272","article-title":"Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort","volume":"80","author":"Geisen","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.04.025","article-title":"Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies","volume":"161","author":"Wong","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.055_bib26","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2021.06.016","article-title":"Humoral immune response to messenger RNA COVID-19 vaccines among patients with inflammatory bowel disease","volume":"161","author":"Kappelman","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.055_bib27","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib28","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/annrheumdis-2021-220597","article-title":"Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease","volume":"80","author":"Haberman","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib29","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/annrheumdis-2021-220461","article-title":"SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases","volume":"80","author":"Simon","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib30","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2665-9913(21)00212-5","article-title":"The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study","volume":"3","author":"Mahil","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.055_bib31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00296-021-04910-7","article-title":"Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly","volume":"41","author":"Seyahi","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1053\/j.gastro.2021.09.055_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/annrheumdis-2021-220781","article-title":"SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity","volume":"80","author":"Mrak","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib33","author":"Medeiros-Ribeiro"},{"key":"10.1053\/j.gastro.2021.09.055_bib34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/annrheumdis-2021-220503","article-title":"Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2","volume":"80","author":"Braun-Moscovici","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib35","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/ced.14631","article-title":"COVID-19 vaccination and psoriatic patients under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers","volume":"46","author":"Damiani","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1053\/j.gastro.2021.09.055_bib36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/annrheumdis-2021-220289","article-title":"Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases","volume":"80","author":"Boyarsky","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bjd.20479","article-title":"Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease","volume":"185","author":"Al-Janabi","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.gastro.2021.09.055_bib38","author":"Bugatti"},{"key":"10.1053\/j.gastro.2021.09.055_bib39","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/ckj\/sfab102","article-title":"Low rates of humoural response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab","volume":"14","author":"Demoulin","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1053\/j.gastro.2021.09.055_bib40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/annrheumdis-2021-220656","article-title":"High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases","volume":"80","author":"Ruddy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib41","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1136\/annrheumdis-2021-220957","article-title":"Correspondence on \u201cSARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response\u201d by Bonelli et\u00a0al","volume":"80","author":"Chung","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib42","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2021-220604","article-title":"Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS-CoV-2 vaccination in patients with rheumatic diseases","volume":"80","author":"Spiera","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.055_bib43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/acr2.11299","article-title":"Impaired antibody response to the BNT162b2 messenger RNA coronavirus disease 2019 vaccine in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"3","author":"Ammitzboll","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.055_bib44","article-title":"Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2","author":"Deepak","year":"2021","journal-title":"medRxiv"},{"key":"10.1053\/j.gastro.2021.09.055_bib45","article-title":"Immunogenicity of COVID-19 Vaccination in immunocompromised patients: an observational, prospective cohort study interim analysis","author":"Haidar","year":"2021","journal-title":"medRxiv"},{"key":"10.1053\/j.gastro.2021.09.055_bib46","article-title":"Immunogenicity of the ChAdOx1 nCoV-19 and the BBV152 vaccines in patients with autoimmune rheumatic diseases","author":"Shenoy","year":"2021","journal-title":"medRxiv"},{"key":"10.1053\/j.gastro.2021.09.055_bib47","article-title":"Antibody Responses to SARS-CoV-2 after infection or vaccination in children and young adults with inflammatory bowel disease","author":"Dailey","year":"2021","journal-title":"medRxiv"},{"key":"10.1053\/j.gastro.2021.09.055_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gutjnl-2021-324388","article-title":"Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.055_bib49","article-title":"Spike-antibody responses to ChAdOx1 and BNT162b2 vaccines by demographic and clinical factors (Virus Watch study)","author":"Shrotri","year":"2021","journal-title":"medRxiv"},{"key":"10.1053\/j.gastro.2021.09.055_bib50","author":"Jena"},{"key":"10.1053\/j.gastro.2021.09.055_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110152","article-title":"The importance of cell-mediated immunity in COVID-19-An opinion","volume":"143","author":"Iqbal","year":"2020","journal-title":"Medical Hypotheses"},{"key":"10.1053\/j.gastro.2021.09.055_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jep.13498","article-title":"Preprint manuscripts and servers in the era of coronavirus disease 2019","volume":"27","author":"Nabavi Nouri","year":"2021","journal-title":"J\u00a0Eval Clin Pract"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521036040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521036040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:35:29Z","timestamp":1758036929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521036040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0016508521036040"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2021.09.055","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2021.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute","name":"copyright","label":"Copyright"}]}}